Jim Prutow

Jim Prutow

Jim Prutow is a partner at global management consulting firm PRTM (www.prtm.com). He can be reached at jprutow@prtm.com.

Recent posts

The Personalized Medicine Opportunity–Shifting the Business to Regulated Markets
Life science tool companies have traditionally operated in the “research use only” market—selling equipment and reagents to academic labs, research centers and biopharmaceutical R&D. By selling into the research-only market, these... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Navigating Challenges & Advancing Clinical Development: A Toolkit for Emerging Biotechs
How incorporating more virtual/hybrid trials and decentralized research into clinical development can better integrate healthcare into patients’ real lives and accelerate approval of new medications.
Medpace

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Sponsored · Whitepaper
Potency Assay Development for Cell and Gene Therapy Products
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Absorption Systems

Xconomy on Demand

We offer a number of ways to subscribe for free!